Author

Keiko Yanagihara

Nippon Medical School Tama Nagayama HospitalORCID 0000-0003-2708-4550Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

Andre Kajdacsy‐BallaiD· 1 shared Debra A. TonettiiD· 1 shared Fouad AlaniiD· 1 shared Geoffrey L. GreeneiD· 1 shared Huiping ZhaoiD· 1 shared Jonathan L. ColoffiD· 1 shared Jonna M. FrasoriD· 1 shared Kent F. HoskinsiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andre Kajdacsy‐BallaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintSep 16, 2026

Integrative pipeline to profile and target endocrine therapy-insensitive cell populations in ER+ breast cancer

Svetlana E. Semina, Rosemary J. Huggins, Huiping Zhao…·Jonathan L. Coloff

The paper develops an analytical pipeline to identify and target endocrine therapy-insensitive cells in ER+ breast cancer using single-cell RNA sequencing and functional validation in organoid models.

DOI 10.64898/2026.09.10.750719

humanscRNA-seq

𝕏 PostBluesky